McCain Tracey L

CIK 00016836003 companiesCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001683600

Recent Transactions

50 trades

Disposition to Issuer
Blueprint Medicines Corp
Common Stock
2025-07-17−51,103→ 37,092 total
Disposition to Issuer
Blueprint Medicines Corp
Stock Option (Right to Buy)
2025-07-17−39,000→ 0 total
Disposition to Issuer
Blueprint Medicines Corp
Stock Option (Right to Buy)
2025-07-17−55,000→ 0 total
Disposition from Tender
Blueprint Medicines Corp
Common Stock
2025-07-17−37,092→ 0 total
Disposition to Issuer
Blueprint Medicines Corp
Stock Option (Right to Buy)
2025-07-17−22,000→ 0 total
Disposition to Issuer
Blueprint Medicines Corp
Stock Option (Right to Buy)
2025-07-17−25,000→ 0 total
Disposition to Issuer
Blueprint Medicines Corp
Stock Option (Right to Buy)
2025-07-17−29,900→ 0 total
Disposition to Issuer
Blueprint Medicines Corp
Stock Option (Right to Buy)
2025-07-17−25,000→ 0 total
Disposition to Issuer
Blueprint Medicines Corp
Stock Option (Right to Buy)
2025-07-17−25,000→ 0 total
Disposition to Issuer
Blueprint Medicines Corp
Stock Option (Right to Buy)
2025-07-17−26,125→ 0 total
Disposition to Issuer
Blueprint Medicines Corp
Stock Option (Right to Buy)
2025-07-17−28,500→ 0 total
Award
Blueprint Medicines Corp
Common Stock
2025-07-17+21,353→ 88,195 total
Disposition to Issuer
Blueprint Medicines Corp
Stock Option (Right to Buy)
2025-07-17−5,000→ 0 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Share
2025-06-05+3,173→ 12,546 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Restricted Share Units
2025-06-05−3,173→ 0 total
Award
Kiniksa Pharmaceuticals International, plc$KNSA
Share Option
2025-06-03+16,798→ 16,798 total
Award
Kiniksa Pharmaceuticals International, plc$KNSA
Restricted Share Units
2025-06-03+2,799→ 2,799 total
Sale
Blueprint Medicines Corp
Common Stock
2025-03-05$88.80/sh−5,262→ 66,583 total
Award
Blueprint Medicines Corp
Stock Option (Right to Buy)
2025-03-01+22,000→ 22,000 total
Award
Blueprint Medicines Corp
Common Stock
2025-03-01+11,000→ 71,845 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Common Share
2024-06-06+4,373→ 9,373 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Restricted Share Units
2024-06-06−4,373→ 0 total
Award
Kiniksa Pharmaceuticals International, plc$KNSA
Share Option
2024-06-05+19,040→ 19,040 total
Award
Kiniksa Pharmaceuticals International, plc$KNSA
Restricted Share Units
2024-06-05+3,173→ 3,173 total
Sale
Blueprint Medicines Corp
Common Stock
2024-03-07$90.69/sh−5,194→ 60,498 total
Award
Blueprint Medicines Corp
Common Stock
2024-03-01+12,500→ 65,692 total
Award
Blueprint Medicines Corp
Stock Option (Right to Buy)
2024-03-01+25,000→ 25,000 total
Disposition to Issuer
ImmunoGen, Inc.
Stock Option (right to buy)
2024-02-12−25,556→ 0 total
Disposition to Issuer
ImmunoGen, Inc.
Stock Option (right to buy)
2024-02-12−19,597→ 0 total
Disposition to Issuer
ImmunoGen, Inc.
Stock Option (right to buy)
2024-02-12−44,000→ 0 total
Disposition to Issuer
ImmunoGen, Inc.
Restricted Stock Unit
2024-02-12−13,090→ 0 total
Disposition to Issuer
ImmunoGen, Inc.
Deferred Share Unit
2024-02-12−50,303→ 0 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Common Share
2023-06-29+5,000→ 5,000 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Restricted Share Units
2023-06-29−5,000→ 0 total
Award
ImmunoGen, Inc.
Stock Option (right to buy)
2023-06-14+19,597→ 19,597 total
Award
ImmunoGen, Inc.
Restricted Stock Unit
2023-06-14+13,090→ 13,090 total
Award
Kiniksa Pharmaceuticals International, plc$KNSA
Share Option
2023-06-06+26,236→ 26,236 total
Award
Kiniksa Pharmaceuticals International, plc$KNSA
Restricted Share Units
2023-06-06+4,373→ 4,373 total
Sale
Blueprint Medicines Corp
Common Stock
2023-03-06$44.41/sh−106→ 52,666 total
Sale
Blueprint Medicines Corp
Common Stock
2023-03-06$45.72/sh−3,216→ 52,772 total
Award
Blueprint Medicines Corp
Common Stock
2023-03-01+12,500→ 55,988 total
Award
Blueprint Medicines Corp
Stock Option (Right to Buy)
2023-03-01+25,000→ 25,000 total
Award
ImmunoGen, Inc.
Deferred Share Unit
2022-12-30+2,772→ 50,303 total
Award
ImmunoGen, Inc.
Stock Option (right to buy)
2022-11-15$5.68/sh+44,000→ 44,000 total
Award
ImmunoGen, Inc.
Deferred Share Unit
2022-11-15+30,000→ 30,000 total
Award
ImmunoGen, Inc.
Deferred Share Unit
2022-09-30+2,876→ 47,531 total
Award
ImmunoGen, Inc.
Deferred Share Unit
2022-06-30+3,055→ 44,655 total
Award
Kiniksa Pharmaceuticals International, plc$KNSA
Restricted Share Units
2022-06-29+5,000→ 5,000 total
Award
Kiniksa Pharmaceuticals International, plc$KNSA
Share Option
2022-06-29+30,000→ 30,000 total
Award
ImmunoGen, Inc.
Deferred Share Unit
2022-06-15+8,712→ 41,600 total

Companies

Recent Filings

Address

C/O BLUEPRINT MEDICINES CORPORATION 45 SIDNEY STREET

CAMBRIDGE, MA, 02139

View on SEC.gov